2-(10-Hydroxydecyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione 2-(10-羟基癸基)-5,6-二甲氧基-3-甲基-1.4-苯醌
CAS 58186-27-9 MFCD00274552
化学结构图
SMILES: COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O
化学属性
| Mol. Formula | C19H30O5 |
|---|---|
| Mol. Weight | 338 |
| Melting Point | 51.0 to 55.0 deg-C |
别名和识别编码
| Chemical Name | 2-(10-Hydroxydecyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione |
|---|---|
| CAS Number | 58186-27-9 |
| Synonym | Daruma Idebenone Avan CV 2619 Idevenone 2,3-Dimethoxy-6-(10-hydroxydecyl)-5-methyl-1,4-benzoquinone 6-(10-Hydroxydecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinone 2-(10-Hydroxydecyl)-5,6-methoxy-3-methyl-2,5-cyclohexadiene-1,4-dione Mnesis |
| Chemical Name Translation | 2-(10-羟基癸基)-5,6-二甲氧基-3-甲基-1.4-苯醌 |
| MDL Number | MFCD00274552 |
| Beilstein Registry Number | 2001459 |
| LabNetwork Molecule ID | LN00194306 |
| Reaxys-RN | 2001459 |
| PubChem Substance ID | 160871272 |
| Merck Number | 4888 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- Aromatics
- Pharmaceuticals
- Intermediates & Fine Chemicals,
产品应用
- Ubiquinone derivative with protective effects against cerebral ischemia. Nootropic.
相关文献及参考
- Barkworth, M.F., et al.: Arzneim.-Forsch., 35, 1704 (1985),
- Kobayashi, T., et al.: J. Pharmacobio-Dyn., 8, 448 (1985),
- Zs-Nagy, I., et al.: Arch. Gerontol. Geriatr., 11, 177 (1990),
安全信息
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : >10 gm/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 13,3931,1985
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 10 gm/kg TOXIC EFFECTS : Sense Organs and Special Senses (Eye) - lacrimation Lungs, Thorax, or Respiration - other changes Gastrointestinal - hypermotility, diarrhea REFERENCE : YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 13,3931,1985
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 830 mg/kg TOXIC EFFECTS : Behavioral - somnolence (general depressed activity) Lungs, Thorax, or Respiration - respiratory depression Nutritional and Gross Metabolic - body temperature decrease REFERENCE : YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (R
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 757 mg/kg TOXIC EFFECTS : Behavioral - somnolence (general depressed activity) Lungs, Thorax, or Respiration - respiratory depression Nutritional and Gross Metabolic - body temperature decrease REFERENCE : YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saie
